Open Access
Hepatitis C viruses : genomes and molecular biology
TLDR
The HCV Genome and Life Cycle, Recombinant Vesicular Stomatitis Virus (VSV) and Other Strategies in HCV Vaccine Designs and Immunotherapy, and Animal Models for HCV Study are described.Abstract:
Introduction: Hepatitis C 1. HCV Genome and Life Cycle 2. HCV 5' and 3'UTR: When Translation Meets Replication 3. Assemble and Interact: Pleiotropic Functions of the HCV Core Protein 4. HCV Glycoproteins: Assembly of a Functional E1-E2 Heterodimer 5. HCV NS2/3 Protease 6. HCV NS3-4A Serine Protease 7. HCV Helicase: Structure, Function, and Inhibition 8. HCV NS4B: from Obscurity to Central Stage 9. HCV NS5A: A Multifunctional Regulator of Cellular Pathways and Virus Replication 10. Biochemical Activities of the HCV NS5B RNA-Dependent RNA Polymerase 11. HCV Replicon Systems 12. Animal Models for HCV Study 13. HCV Regulation of Host Defense 14. Regulation of Adaptive Immunity by HCV 15. Recombinant Vesicular Stomatitis Virus (VSV) and Other Strategies in HCV Vaccine Designs and Immunotherapy 16. Development of an Infectious HCV Cell Culture Systemread more
Citations
More filters
Journal ArticleDOI
Antiviral treatment of hepatitis C
Eoin R. Feeney,Raymond T. Chung +1 more
TL;DR: The NS3/4A inhibitor simeprevir and NS5B inhibitor sofosbuvir have recently been licensed and can reduce the length of antiviral treatment, improve response rates, and allow for interferon-free regimens for some HCV genotypes.
Journal ArticleDOI
Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication?
TL;DR: Understanding the process of NS5A phosphorylation and the definite identification of the culprit cellular protein kinase(s) will shed light on the mechanisms of HCV RNA replication and/or pathogenesis.
Journal ArticleDOI
Hepatitis C virus: virology and life cycle.
Chang Wook Kim,Kyong-Mi Chang +1 more
TL;DR: Various aspects of HCV life cycle including viral attachment, entry, fusion, viral RNA translation, posttranslational processing, HCV replication, viral assembly and release provides potential targets for novel antiviral therapeutics to cure HCV infection and prevent the adverse consequences of progressive liver disease.
Book ChapterDOI
Viral protease inhibitors.
TL;DR: The biochemistry of HIV-1 protease, inhibitor development, clinical use of inhibitors, and evolution of resistance are discussed, as well as other viral proteases as potential drug targets, including those from Dengue virus, cytomegalov virus, rhinovirus, and coronavirus.
Journal ArticleDOI
Proteases and protease inhibitors in infectious diseases
TL;DR: This review discusses the chemical and biological makeup of some key druggable proteases expressed by the five major classes of disease causing agents, namely bacteria, viruses, fungi, eukaryotes, and prions and assess the mechanism of action and clinical performance of the protease inhibitors against infectious agents.
Related Papers (5)
Complete Replication of Hepatitis C Virus in Cell Culture
Brett D. Lindenbach,Brett D. Lindenbach,Brett D. Lindenbach,Matthew J. Evans,Matthew J. Evans,Matthew J. Evans,Andrew J. Syder,Andrew J. Syder,Andrew J. Syder,Benno Wölk,Benno Wölk,Benno Wölk,Timothy L. Tellinghuisen,Timothy L. Tellinghuisen,Timothy L. Tellinghuisen,Christopher C. Liu,Christopher C. Liu,Christopher C. Liu,Toshiaki Maruyama,Toshiaki Maruyama,Toshiaki Maruyama,Richard O. Hynes,Richard O. Hynes,Richard O. Hynes,Dennis R. Burton,Dennis R. Burton,Dennis R. Burton,Jane A. McKeating,Jane A. McKeating,Jane A. McKeating,Charles M. Rice,Charles M. Rice,Charles M. Rice +32 more